�鶹��ýӰ��

Mike Bassett

Mike Bassett

Authors >

Mike Bassett

Mike Bassett is a staff writer for MedPage Today focusing on oncology and hematology. He has over 20 years of journalism experience, including a dozen years covering medicine and healthcare. Based in Massachusetts, he has degrees from Boston University and George Washington University and spends much of his free time either watching or playing soccer.

Connect:

email image

Latest from Mike Bassett

A photo of a flexible colonoscope.

Lasting Reductions in CRC Incidence, Death With Single Sigmoidoscopy

But editorialists call USPSTF-recommended screening option "outdated"

A photo of a female radiologist positioning her female patient for digital breast tomosynthesis.

Adding MRI to DBT Screening in Women With Dense Breasts May Avert More Cancer Deaths

But benefit in modeling study accompanied by more false-positive biopsy recommendations

A photo composite of vials of Opdivo and Yervoy over a computer rendering of lung cancer.

Trial Questions Role of Dual Immunotherapy in First-Line NSCLC

In Japanese trial, nivolumab-ipilimumab didn't improve OS versus pembrolizumab, had more toxicity

A CT scan of healthy lungs.

Researchers Challenge USPSTF's Lung Cancer Screening Criteria

Alternate criteria based on years of smoking has higher sensitivity and specificity, study says

A computer rendered cutaway of pancreatic cancer

Dose-Reduced Chemo Regimen Promising in Metastatic Pancreatic Cancer

Alternating cycles of nab-paclitaxel-gemcitabine and gemcitabine alone boosted tolerability

FDA APPROVED lazertinib (Lazcluze) over a computer rendering of lung cancer.

Targeted First-Line Combo Approved for EGFR-Mutated Lung Cancer

Lazertinib plus amivantamab improved PFS by about 7 months versus single-agent osimertinib

A photo of surgeons performing axillary surgery.

Study: Avoid Completion ALND for Abemaciclib Eligibility in Early Breast Cancer

Researchers suggest unfavorable risk-benefit ratio "disqualifies" it as a staging tool

A close up photo of a man smoking a marijuana cigarette.

Heavy Cannabis Use Tied to Increased Head and Neck Cancer Risk

Study findings have "substantial public health implications," researchers say

FDA APPROVED vorasidenib (Voranigo) over a computer rendering of a brain tumor.

FDA Approves Vorasidenib for IDH-Mutant Gliomas

Treatment improved PFS by 16 months compared with placebo in INDIGO trial

MRI images of a prostate gland.

AI Model as Effective as Radiologists in Detecting Prostate Cancer on MRI

Combined findings from model and radiologists outperformed radiologists alone

…

7

…